1252672-39-1

Basic information

• Product Name: benzyl 4-(hydroxymethyl)bicyclo[2.2.1]heptan-1-ylcarbamate
• Synonyms: benzyl 4-(hydroxymethyl)bicyclo[2.2.1]heptan-1-ylcarbamate
• CAS NO: 1252672-39-1
• Molecular Weight: 275.348
• Mol File: 1252672-39-1.mol

Chemical Properties

• CAS DataBase Reference: benzyl 4-(hydroxymethyl)bicyclo[2.2.1]heptan-1-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 4-(hydroxymethyl)bicyclo[2.2.1]heptan-1-ylcarbamate(1252672-39-1)
• EPA Substance Registry System: benzyl 4-(hydroxymethyl)bicyclo[2.2.1]heptan-1-ylcarbamate(1252672-39-1)

Safety Data

• Hazardous Substances Data: 1252672-39-1(Hazardous Substances Data)

Upstream product

• 15448-76-7 dimethyl bicyclo<2.2.1>heptane-1,4-dicarboxylate 
• 1252672-35-7 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid methyl ester 
• 15448-77-8 4-carbomethoxybicyclo<2.2.1>heptane-1-carboxylic acid 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS

This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF

The present invention relates to inhibitors of 11-β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.